A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT
Background: The EndoBarrier® (GI Dynamics Inc., Boston, MA, USA) is an endoluminal duodenal–jejunal bypass liner developed for the treatment of patients with obesity and type 2 diabetes mellitus. Meta-analyses of its effects on glycaemia and weight have called for larger randomised controlled trials...
Main Authors: | Aruchuna Ruban, Michael A Glaysher, Alexander D Miras, Anthony P Goldstone, Christina G Prechtl, Nicholas Johnson, Jia Li, Madhawi Aldhwayan, Ghadah Aldubaikhi, Ben Glover, Joanne Lord, Olu Onyimadu, Emmanuela Falaschetti, Natalia Klimowska-Nassar, Hutan Ashrafian, James Byrne, Julian P Teare |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2020-11-01
|
Series: | Efficacy and Mechanism Evaluation |
Subjects: | |
Online Access: | https://doi.org/10.3310/eme07060 |
Similar Items
-
Measurement of hepatic insulin sensitivity early after the bypass of the proximal small bowel in humans
by: A. D. Miras, et al.
Published: (2017-03-01) -
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus
by: Anna Obermayer, et al.
Published: (2021-04-01) -
Restoration of myocardial glucose uptake with facilitated myocardial glucose transporter 4 translocation contributes to alleviation of diabetic cardiomyopathy in rats after duodenal‐jejunal bypass
by: Xin Huang, et al.
Published: (2019-05-01) -
Effects and mechanism of duodenal-jejunal bypass and sleeve gastrectomy on GLUT2 and glucokinase in diabetic Goto–Kakizaki rats
by: Donglei Zhou, et al.
Published: (2012-06-01) -
The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
by: Yi Gao, et al.
Published: (2021-04-01)